Beta Bionics, Inc.

Analysis for Ticker: BBNX

Beta Bionics Inc builds automated insulin delivery systems like the iLet Bionic Pancreas to help people manage diabetes without manual calculations. On the surface, it looks like a medical technology company, but the math reveals a machine designed to move money from the public to a small group of insiders while the business itself falls apart. By 12/2025, three top executives extracted over 21,0$ million in compensation while the company recorded a net loss of 73,2$ million. The financial math is a disaster because for every 1,00$ the company earns, it spends 1,71$ just to stay alive. It is like a child who sells lemonade for 1,00$ but spends 1,71$ on the lemons and the cup, all while the parents take the coins out of the jar before the child can pay for more sugar.